ConductScience.org, home

Paper41379101

Discovery of Zilucoplan: A Complement C5 Inhibitor for Treatment of Anti-Acetylcholine Receptor (AChR) Antibody-Positive Generalized Myasthenia Gravis (gMG).

Ye P and 8 others. J Med Chem, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Discovery of Zilucoplan: A Complement C5 Inhibitor for Treatment of Anti-Acetylcholine Receptor (AChR) Antibody-Positive Generalized Myasthenia Gravis (gMG). Papers, record 41379101. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41379101

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Discovery of Zilucoplan: A Complement C5 Inhibitor for Treatment of Anti-Acetylcholine Receptor (AChR) Antibody-Positive Generalized Myasthenia Gravis (gMG).
PubMed
Journal
J Med Chem
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-01-01
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ye PPinghttps://orcid.org/0009-0000-9645-1495
2Hammer RPRobert P
3Wang ZZhaolin
4Dhamnaskar KKetki
5Hoarty MMichelle
6Ma ZZhong
7Tang GQGuo-Qing
8DeMarco SJSteven Jhttps://orcid.org/0009-0004-6948-6501
9Ricardo AAlonso

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Myasthenia GravisMajor topic
Complement C5Major topic
Peptides, CyclicMajor topic
Receptors, CholinergicMajor topic
Humans
Animals
Drug Discovery
Structure-Activity Relationship

Source PubMed

Download CSV of topics

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131050279Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder.N Engl J Med2019https://conductscience.org/library/papers/31050279PubMed
219730437Complement regulators and inhibitory proteins.Nat Rev Immunol2009https://conductscience.org/library/papers/19730437PubMed
324521109Genetic variants in C5 and poor response to eculizumab.N Engl J Med2014https://conductscience.org/library/papers/24521109PubMed
416990386The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.N Engl J Med2006https://conductscience.org/library/papers/16990386PubMed
532582144Complement Inhibitor Therapy for Myasthenia Gravis.Front Immunol2020https://conductscience.org/library/papers/32582144PubMed
635730504Role of complement, anti-complement therapeutics, and other targeted immunotherapies in myasthenia gravis.Expert Rev Clin Immunol2022https://conductscience.org/library/papers/35730504PubMed
730395448RNA Display Methods for the Discovery of Bioactive Macrocycles.Chem Rev2019https://conductscience.org/library/papers/30395448PubMed
832882310C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial.Ophthalmology2021https://conductscience.org/library/papers/32882310PubMed
926308095Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide.J Med Chem2015https://conductscience.org/library/papers/26308095PubMed
1029655452Treatment of Myasthenia Gravis.Neurol Clin2018https://conductscience.org/library/papers/29655452PubMed
1124157402mRNA display: from basic principles to macrocycle drug discovery.Drug Discov Today2014https://conductscience.org/library/papers/24157402PubMed
1222094817In vitro selection of unnatural cyclic peptide libraries via mRNA display.Methods Mol Biol2012https://conductscience.org/library/papers/22094817PubMed
138554512Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo.Biochem J1995https://conductscience.org/library/papers/8554512PubMed
1437622108Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activation.Front Immunol2023https://conductscience.org/library/papers/37622108PubMed
1533170686Series of Novel and Highly Potent Cyclic Peptide PCSK9 Inhibitors Derived from an mRNA Display Screen and Optimized via Structure-Based Design.J Med Chem2020https://conductscience.org/library/papers/33170686PubMed
1631209353A small-molecule inhibitor of C5 complement protein.Nat Chem Biol2019https://conductscience.org/library/papers/31209353PubMed
1733730455Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria.N Engl J Med2021https://conductscience.org/library/papers/33730455PubMed
1833792453Zilucoplan: An Investigational Complement C5 Inhibitor for the Treatment of Acetylcholine Receptor Autoantibody-Positive Generalized Myasthenia Gravis.Expert Opin Investig Drugs2021https://conductscience.org/library/papers/33792453PubMed
1915049843Facile preparation of disulfide-bridged peptides using the polymer-supported oxidant CLEAR-OX.J Pept Res2004https://conductscience.org/library/papers/15049843PubMed
2024088106Eculizumab in atypical hemolytic-uremic syndrome.N Engl J Med2013https://conductscience.org/library/papers/24088106PubMed

See all 22 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42866003Development of a Lactam-Bridged Peptide as Interleukin-11 Antagonist for Renal Fibrosis Treatment.ACS Med Chem Lett2026https://conductscience.org/library/papers/42866003PubMed
42714778Neuroimmune interactions: from molecular mechanisms to therapeutic targets.Mol Biomed2026https://conductscience.org/library/papers/42714778PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
C5727PubTator's text mininghttps://conductscience.org/library/genes/727

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41379101

GET https://conductscience.org/api/papers/v1/41379101/references?page=2